Avastin for Post-photocoagulation Macular Edema

Prevention of Post-photocoagulation Macular Edema by Intravitreal Bevacizumab.

to evaluate the efficacy of a single intravitreal bevacizumab (IVB) injection, 0.1mL (2.5mg), against panretinal photocoagulation (PRP)-induced macular thickening and visual disturbance in patients with severe nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) and good vision

Inclusion Criteria:

• Patients with Proliferative retinopathy or severe non-proliferative retinopathy
• BCVA of 20/63 or better (56 ETDRS letters
• No history of Macular Edema
• Central Retinal Thickness of 250mics or more

Exclusion Criteria:

• Previous treatment.
• Other ophthalmic diseases. history of Nephropathy, heart diseases and pregnancy
• Media opacities